THANK YOU FOR SUBSCRIBING


Dr. Song Li, Founder and CEOOffering round-the-clock support to fast-track and fulfill the drug development goals of pharma, biotech, and life sciences companies is Frontage Laboratories. “We provide integrated pharmaceutical product development services that clients need at each stage of the drug discovery and development process,” says Dr. Song Li, founder and CEO of Frontage Laboratories. The clinical research organization (CRO) offers a host of comprehensive, cost-effective clinical services that include drug metabolism and pharmacokinetics, bioanalysis, analytical testing, formulation creation, preclinical and clinical trial material manufacturing, preclinical safety and toxicology evaluation, and early phase clinical investigation.
Frontage assists various biotech and pharma companies across the globe in accelerating their compounds through the development process and achieving regulatory approval for their drugs. The company’s qualified team of pharmaceutical industry experts addresses the myriad drug development challenges of life sciences startups as well as that of big pharma. For small pharma companies and startups struggling with a lack of industry expertise, Frontage provides consultations and recommendations on the best course to follow during the development stages. In addition to regular clinical services, Frontage also arranges the necessary funds required by these companies from investors. For big pharma companies, the company engages with external industry experts to expedite their drug development projects.
The key differentiators enabling Frontage to deliver unmatched pharmaceutical product development services are its three core strengths—an illustrious scientific team, advanced laboratories, and stringent quality control measures. The company’s highly accomplished scientific team comprising a significant percentage of Masters and Ph.D. degree holders enables Frontage to solve some of the more complex issues surrounding drug development compared to other industry players. In terms of laboratory facilities, the company possesses advanced clinical centers and impressive lab spaces in the US and China furnished with state-of-the-art testing equipment. Moreover, Frontage’s strict quality testing methods are aligned to GCP, GMP, and GRP standards and adhere to FDA regulations, ensuring the best outcomes for clients in their drug development journey.
Frontage’s expertise in facilitating and streamlining drug discovery and development has enabled it to serve some of the biggest names in the pharma segment. In the early days of the company, Frontage developed an effective preclinical drug validation method for a leading Philadelphia-based pharma company’s drug testing project, and they continue to be devoted clients. Similarly, for another renowned Bostonbased biotech company, Frontage designed a formulation method for testing their nanotechnology-based injectable drug during the preclinical stage. The FDA lauded the method’s efficacy, which served as a decisive factor in the drug getting FDA-approved. With a long streak of success that continues to grow with each passing day, Frontage envisions surging ahead in the world of pharmaceuticals and standing a class apart in the CRO space.
Company
Frontage Laboratories
Management
Dr. Song Li, Founder and CEO
Description
Frontage Laboratories, Inc. is a CRO that provides integrated, science-driven, product development services throughout the drug discovery and development process to enable pharmaceutical and biotechnology companies to achieve their development goals. Comprehensive services include drug metabolism and pharmacokinetics, analytical testing and formulation development.